We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Glenmark Pharmaceuticals Ltd and Shasun Chemicals and Drugs Ltd have entered
into a collaboration agreement for the joint development, filing and marketing
of twelve generic pharmaceutical products for the U.S. market.
Allergan, Inc. announced it has entered into an exclusive licensing agreement
with Sanwa Kagaku Kenkyusho Co., Ltd. (Sanwa) to develop and commercialize POSURDEX
for the ophthalmic specialty market in Japan.
Dr. Reddy's Laboratories announced that the company has entered into a US$56
million agreement with ICICI Venture Funds Management Company for the development
and commercialization of ANDAs to be filed in 2004-05 and 2005-06.
Yamanouchi Pharmaceutical announced that it has discovered a promising target
molecule for the development of anti-obesity and antidiabetic drug, in collaboration
with Keio University.
Teva Pharmaceutical Industries Ltd., the world's biggest generic-drug
maker, said its version of Pfizer's blood-pressure medicine Norvasc received
tentative approval from the US FDA, according to a report from Bloomberg.
Fast-track recruitment has begun for a trial to investigate the safety
of a vaccine against H5N1 avian influenza, according to the National Institute
of Allergy and Infectious Diseases (NIAID), part of the National Institutes
of Health.
The US FDA has approved a once-monthly version Boniva tablets, an osteoporosis
treatment marketed jointly by Swiss drugmaker Roche and the UK's GlaxoSmithKline.
Ferring Pharmaceutical (China) Co Ltd's opening of its manufacturing
site at the Zhongshan port — the Swiss company's first production facility
in Asia — is the latest move in Ferring's impressive campaign to extend
its operations well beyond its traditional base in Europe.